Skip to main content
Kenneth Stoller, MD, Psychiatry, Baltimore, MD

KennethBruceStollerMD

Psychiatry Baltimore, MD

Addiction

Professor of Clinical Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine; Director, Johns Hopkins Broadway Center for Addiction; Medical Director, Behavioral Health, Johns Hopkins HealthCare, LLC

Dr. Stoller is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Stoller's full profile

Already have an account?

  • Office

    4940 Eastern Avenue
    Baltimore, MD 21224
    Phone+1 410-550-0100
    Fax+1 410-550-0101

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Psychiatry, 1992 - 1996
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1992
  • University of Maryland, College Park
    University of Maryland, College ParkBS, Zoology (University Honors Program), Summa Cum Laude, 1988

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1995 - 2025
  • FL State Medical License
    FL State Medical License 2016 - 2018
  • American Board of Psychiatry and Neurology Psychiatry
  • American Board of Preventive Medicine Addiction Medicine

Awards, Honors, & Recognition

  • Nyswander/Dole Award The American Association for the Treatment of Opioid Dependence, 2016
  • Nominated for “Clinical Collaboration and Teamwork Award for Clinical Excellence.” Johns Hopkins Medicine's Office of Johns Hopkins Physicians, 2015
  • Top Manager Johns Hopkins Medicine, 2013
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Office-based buprenorphine maintenance: Setting the stage for success  
    Stoller, K.B., King, V.L., Clark, M.R., Brooner, R.K., Advanced Studies in Medicine, 1/1/2006
  • DSM-III-R versus DSM-IV substance use disorders: Concordance in drug users homogeneous for chronic and severe problems  
    Stoller, K.B., King, V.L., Kidorf, M.S., Neufeld, K.S., Brooner, R.K., Addictive Disorders and Their Treatment, 1/1/2006
  • Influence of antisocial personality subtypes on drug abuse treatment response  
    King, V.L., Kidorf, M.S., Stoller, K.B., Carter, J.A., Brooner, R.K., Journal of Nervous and Mental Disease., 1/1/2001
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • A collaborative opioid prescribing (CoOP) model linking opioid treatment programs with office-based buprenorphine providers.
    Stoller, K.B., Addiction Science & Clinical Practice, 1/1/2015
  • Synthetic cannabinoid use and awareness in a drug abuse treatment clinic.
    Disney, E. Stoller, K.B., Vandrey, R., Drug & Alcohol Dependence, 1/1/2015
  • Early treatment response to a “Motivated Stepped Care” approach using LAAM: Comparison with methadone study.
    Stoller, K.B., Carter, J.A., King, V.L., Kidorf, M.S,, Brooner, R.K., American Journal on Addictions, 1/1/2003
  • Join now to see all

Lectures

  • Transforming Addiction Treatment through Innovative Models of Care: Insights from Maryland 
    Baltimore, Maryland - 1/1/2016
  • Medication Assisted Treatment: Opportunities for Community Centers. 
    San Antonio, TX - 1/1/2016
  • Increasing Office-Based Buprenorphine Availability and Efficacy through Coordination with Opioid Treatment Programs 
    Huntington Beach, California. - 1/1/2015
  • Join now to see all

Other

  • An Opioid Treatment Model Spawns Imitators 
    Christine Vestal (The Pew Charitable Trusts/Stateline), Huffington Post, Baltimore Sun, CSPAN, Chicago Tribune, LA Times, Partnership for Drug-Free Kids, Pr
    http://www.huffingtonpost.com/entry/opioid-addiction-treatment_us_5720cf65e4b0b49df6a9b96a
    1/1/2016
  • Improving MAT Access and Quality Through Collaborative Care: The CoOP Model. 
    American Psychiatric Association sponsored national webinar for SAMHSA’s Provider Clinical Support S
    1/1/2016
  • ONDCP Director Botticelli article in ATTC Messenger 

    http://www.attcnetwork.org/Botticelli%20-%20MAT%20Article%20for%20ATTC%20Messenger%2020150819%20COS%20Approved%20v3.pdf
    1/1/2015
  • Join now to see all

Press Mentions

  • During Pandemic, Maryland’s Drug Treatment Clinics Grapple with Health Safety Issues, Rising Caseloads
    During Pandemic, Maryland’s Drug Treatment Clinics Grapple with Health Safety Issues, Rising CaseloadsJuly 27th, 2020
  • Pandemic Creates Challenges, New Opportunities for Treating Patients with Substance Use Disorder
    Pandemic Creates Challenges, New Opportunities for Treating Patients with Substance Use DisorderMay 12th, 2020
  • Long Drive Times in Rural Areas May Be a Barrier to Opioid Addiction Treatment
    Long Drive Times in Rural Areas May Be a Barrier to Opioid Addiction TreatmentOctober 2nd, 2019
  • Join now to see all